Liu Chao, Chang Le, Jia Tingting, Guo Fei, Zhang Lu, Ji Huimin, Zhao Junpeng, Wang Lunan
National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology, No1 Dahua Road, Dongdan, Beijing, 100730, People's Republic of China.
Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, People's Republic of China.
Virol J. 2017 May 12;14(1):94. doi: 10.1186/s12985-017-0759-8.
Quantification Hepatitis B virus (HBV) DNA plays a critical role in the management of chronic HBV infections. However, HBV is a DNA virus with high levels of genetic variation, and drug-resistant mutations have emerged with the use of antiviral drugs. If a mutation caused a sequence mismatched in the primer or probe of a commercial DNA quantification kit, this would lead to an underestimation of the viral load of the sample. The aim of this study was to determine whether commercial kits, which use only one pair of primers and a single probe, accurately quantify the HBV DNA levels and to develop an improved duplex real-time PCR assay.
We developed a new duplex real-time PCR assay that used two pairs of primers and two probes based on the conserved S and C regions of the HBV genome. We performed HBV DNA quantitative detection of HBV samples and compared the results of our duplex real-time PCR assays with the COBAS TaqMan HBV Test version 2 and Daan real-time PCR assays. The target region of the discordant sample was amplified, sequenced, and validated using plasmid.
The results of the duplex real-time PCR were in good accordance with the commercial COBAS TaqMan HBV Test version 2 and Daan real-time PCR assays. We showed that two samples from Chinese HBV infections underestimated viral loads when quantified by the Roche kit because of a mismatch between the viral sequence and the reverse primer of the Roche kit. The HBV DNA levels of six samples were undervalued by duplex real-time PCR assays of the C region because of mutations in the primer of C region.
We developed a new duplex real-time PCR assay, and the results of this assay were similar to the results of commercial kits. The HBV DNA level could be undervalued when using the COBAS TaqMan HBV Test version 2 for Chinese HBV infections owing to a mismatch with the primer/probe. A duplex real-time PCR assay based on the S and C regions could solve this problem to some extent.
乙型肝炎病毒(HBV)DNA定量在慢性HBV感染的管理中起着关键作用。然而,HBV是一种具有高度遗传变异的DNA病毒,随着抗病毒药物的使用出现了耐药突变。如果突变导致商业DNA定量试剂盒的引物或探针序列不匹配,这将导致样本病毒载量的低估。本研究的目的是确定仅使用一对引物和单个探针的商业试剂盒是否能准确量化HBV DNA水平,并开发一种改进的双链实时PCR检测方法。
我们基于HBV基因组的保守S和C区域开发了一种新的双链实时PCR检测方法,该方法使用两对引物和两个探针。我们对HBV样本进行了HBV DNA定量检测,并将我们的双链实时PCR检测结果与COBAS TaqMan HBV检测版本2和达安实时PCR检测结果进行了比较。对不一致样本的目标区域进行扩增、测序,并使用质粒进行验证。
双链实时PCR结果与商业COBAS TaqMan HBV检测版本2和达安实时PCR检测结果高度一致。我们发现,来自中国HBV感染的两个样本在用罗氏试剂盒定量时,由于病毒序列与罗氏试剂盒的反向引物不匹配,导致病毒载量被低估。由于C区域引物的突变,六个样本的HBV DNA水平在C区域的双链实时PCR检测中被低估。
我们开发了一种新的双链实时PCR检测方法,该方法的结果与商业试剂盒的结果相似。对于中国HBV感染,使用COBAS TaqMan HBV检测版本2时,由于与引物/探针不匹配,HBV DNA水平可能被低估。基于S和C区域的双链实时PCR检测方法可以在一定程度上解决这个问题。